Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy

Nature Medicine

Volumn 6, Issue 4, 2000, Pages 405-413

  Schratzberger, Peter ^a   Schratzberger, Gabriele ^a   Silver, Marcy ^a   Curry, Cynthia ^a   Kearney, Marianne ^a   Magner, Meredith ^a   Alroy, Joseph ^a   Adelman, Lester S ^a   Weinberg, David H ^a   Ropper, Allan H ^a   Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; LIMB ISCHEMIA; NERVE CONDUCTION; NERVE FUNCTION; NEUROPATHY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RABBIT;

ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HINDLIMB; ISCHEMIA; LYMPHOKINES; NERVE TISSUE PROTEINS; NEUROPILIN-1; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; PROTO-ONCOGENE PROTEINS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SCHWANN CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 17144474840     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/74664     Document Type: Article

References (44)

1. European Working Group on Critical Leg Ischemia, Second European consensus document on chronic critical leg ischemia. Circulation 84, IV-1-IV-26 (1991).
2. Hunter, G.C., Song, G.W., Nayak, N.N., Zapotowski, D. & Guernsey, J.M. Peripheral nerve conduction abnormalities in lower extremity ischemia: the effects of revascularization. J. Surg. Res. 45, 96-103 (1988).
3. Miglietta, O. Electrophysiologic studies in chronic occlusive peripheral vascular disease. Arch. Phys. Med. Rehabil. 48, 89-96 (1967).
4. Eames, R.A. & Lange, L.S. Clinical and pathological study of ischemic neuropathy. J. Neurol. Neurosurg. Psychiatry 30, 215-226 (1967).
5. Tsurumi, Y. et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94, 3281-3290 (1996).
6. Bauters, C. et al. Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267, H1263-H1271 (1994).
7. Bauters, C. et al. Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21, 314-325 (1995).
8. Bauters, C. et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91, 2802-2809 (1995).
9. Pu, L.Q. et al. A persistent hindlimb ischemia model in the rabbit. J. Invest. Surg. 7, 49-60 (1994).
10. Takeshita, S. et al. Vascular endothelial growth factor induces dose-dependent revascularization in a rabbit model of persistent limb ischemia. Circulation 90, II-228-II-234 (1994).
11. Takeshita, S. et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 227, 628-635 (1996).
12. Takeshita, S. et al. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93, 662-670 (1994).
13. Rivard, A. et al. Age-dependent impairment of angiogenesis. Circulation 99, 111-120 (1999).
14. Isner, J.M. et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 7, 959-988 (1996).
15. Anton, E.S., Weskamp, G., Reichhardt, L.F. & Mattew, W.D. Nerve growth factor and its low affinity receptor promote schwann cell migration. Proc. Natl. Acad. Sci. USA 91, 2795-2799 (1994).
16. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (1998).
17. Patel, M.K., Lymn, J.S., Clunn, G.F. & Hughes, A.D. Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17, 2107-2114 (1997).
18. Mellick, R.S. & Cavanagh, J.B. Changes in blood vessel permeability during degeneration and regeneration in peripheral nerves. Brain 91, 141-160 (1968).
19. Chervu, A., Moore, W.S., Homsher, E. & Quinones-Baldrich, W.J. Differential recovery of skeletal muscle and peripheral nerve function after ischemia and reperfusion. J. Surg. Res. 47, 12-19 (1989).
20. Bentley, F.H. & Schlapp, W. Experiments on the blood supply of nerves. J. Physiol. 102, 62-71 (1943).
21. Blunt, M.J. Ischemic degeneration of nerve fibers. Arch. Neurol. 2, 528-536 (1960).
22. Hobson, M.I., Brown, R., Green, C.J. & Terenghi, G. Inter-relationships between angiogenesis and nerve regeneration: a histochemical study. Br. J. Plast. Surg. 50, 125-131 (1997).
23. Takeshita, S. et al. Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation 95, 805-808 (1997).
24. Takeshita, S. et al. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 98, 1261-1263 (1998).
25. White, F.C., Carroll, S.M., Magnet, A. & Bloor, C.M. Coronary collateral development in swine after coronary artery occlusion. Circ. Res. 71, 1490-1500 (1992).
26. Carroll, S.M., White, F.C., Roth, D.M. & Bloor, C.M. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation 88, 198-207 (1993).
27. Sondell, M., Lundborg, G. & Kanje, M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731-5740 (1999).
28. Sondell, M., Lundborg, g. & Kanje, M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res. 846, 219-228 (1999).
29. Osborne, W.A. & Vincent, S. The physiologic effects of extracts of nervous tissue. J. Physiol. 25, 283-294 (1900).
30. Senger, D.R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985 (1983).
31. Couffinhal, T. et al. A mouse model of angiogenesis. Am. J. Pathol. 152, 1667-1679 (1998).
32. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
33. Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
34. Rivard, A. et al. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154, 355-364 (1999).
35. -1- Mice. Circulation 99, 3188-3198 (1999).
36. Van Belle, E. et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96, 2667-2674 (1997).
37. Morrissey, T.K., Kleitman, N. & Bunge, R.P. Isolation and functional characterization of schwann cells derived from adult peripheral nerve. J. Neurosci. 11, 2433-2442 (1991).
38. McCarthy, J.B., Palm, S.L. & Furcht, L.T. Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J. Cell Biol. 97, 772-777 (1983).
39. Zigmond, S.H. & Hirsch, J.G. Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp Med. 137, 387-410 (1973).
40. Brogi, E. et al. Hypoxia-induced paracrine regulation of VEGF receptor expression. J. Clin. Invest. 97, 469-476 (1996).
41. Spyridopoulos, I., Sullivan, A.B., Kearney, M., Isner, J.M. & Losordo, D.W. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis, estradiol as a survival factor. Circulation 95, 1505-1514 (1997).
42. Buttke, T.M., McCubrey, J.A. & Owen, T.C. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods 157, 233-240 (1993).
43. Murohara, T. et al. Role of endothelial nitric oxide synthase in endotehlial cell migration. Arterioscler. Thromb. Vasc. Biol. 19, 1156-1161 (1999).
44. Kearney, M. et al. Histopathology of in-stent restenosis. Circulation 95, 1998-2002(1997).